Resource Center on Starting HIV Treatment

After years of LGBTQ advocacy pushing for it, a federal agency is likely to make it a whole lot more common for providers to pay attention to “SOGI.”

Exciting new discoveries toward a functional HIV cure are emerging. But we’ll only get there if people with HIV join studies.

The collective harms of racism within mass incarceration contribute greatly to disproportionate HIV prevalence and outcomes within Black communities.

Viread (a.k.a. TDF or tenofovir disoproxil fumarate) turns 20 this year, but it's still a very common medication taken by people living with HIV or as PrEP.

The integrase inhibitor Tivicay is a critical component of some of the most commonly used HIV treatment regimens in the U.S. today.

Deeeply researched and medically reviewed, our "no-BS basics" on Odefsey will get you in the know about the most important info regarding this single-tablet HIV treatment regimen.

What makes this two-drug regimen for HIV so unique? An expert HIV clinician walks us through the details.

The basics on the first HIV integrase inhibitor, including recommended dosing, what its potential side effects are, and how it stacks up against more recently approved drugs in its class.

Get an HIV doc's rundown of the most important info to understand about this three-drug, single-tablet regimen.

A top-notch HIV doctor dishes the details on one of the U.S.'s recommended first-line HIV treatment drugs.